General

• USA: Dr. quits Brigham to speak for pay
  • The pharma marketing hydra (Forbes blog, 28 Jan. 2010)
• FDA wants new studies to assess erythropoiesis-stimulating agents in chronic kidney disease (8 Jan. 2010)
  • Erythropoiesis-stimulating agents — time for a reevaluation (NEJM, 6 Jan. 2010)

| Archives |

| Archives |

Amgen

• Amgen's troubles keep compounding; Aranesp studies reveal greater risks (11 Nov. 2009)
  • Hershman DL, Buono DL, Malin J, McBride R, Tsai WY, Neugut AI. Patterns of use and risks associated with erythropoiesis-stimulating agents among medicare patients with cancer. J Natl Cancer Inst 2009 Nov 10. [Epub ahead of print]
  • NY Attorney General leads multi-state coalition in lawsuit against biotech giant Amgen. Complaint alleges kickbacks to medical providers to increase sales of Aranesp.

| Archives |

Aventis

| Archives |

Baxter

• US hospitals queue for lawsuit against Australia's CSL and Baxter (26 Oct. 2009)

| Archives |

Bayer

| Archives |

bioMerieux

| Archives |

Biopure

• Former Biopure VP gets 3-yr jail sentence & $50,000 fine for faking cancer to avoid SEC lawsuit (6 Oct. 2009)

| Archives |

Cangene

| Archives |

CSL

• Mayo Clinic joins class action lawsuit against Australia's CSL (15 Feb. 2010)
• Uncensored court documents on CSL's failed takeover of Talecris reveal CSL was ''truly scared'' Talecris would raise plasma production & slash industry profitability (23 Nov. 2009)
• US hospitals queue for lawsuit against Australia's CSL and Baxter (26 Oct. 2009)

Haemonetics

• Haemonetics announces plan to buy Global Med Technologies, parent company of Wyndgate Technologies, for $60 million (1 Feb. 2010)
• BloodTrack^® wins best 'Public Sector Project' at the UK IT Computing Awards (25 Jan. 2010)
• Haemonetics buys Neoteric Technology of Vancouver, Canada (Apr. 21, 2009)
  • Neoteric Technology Ltd (website)
• Haemonetics wins $15.7 million from Fenwal in alleged patent infringement case (5 Feb. 2009)

Immucor

• Immucor hit by shareholder lawsuit (28 Aug. 2009)
  • Notice of filing securities class action |  View complaint
• Immucor submits 10-day response to FDA (13 July, 2009: Immucor press release)
• FDA: Notice of Intent to Revoke Letter: Immucor, Inc. (25 June 2009)
  • Immucor's response (press release)
  • Immucor's shares dip following FDA notice to revoke license

| Archives |

Mak

| Archives |

Neoteric Technology

| Archives |

Northfield Laboratories (Polyheme)

| Archives |

Ortho Biotech

| Archives |

Ortho Clinical Diagnostics

| Archives |

Pfizer

• Pfizer hit with biggest criminal fine in US history for mispromoting drugs &  paying kickbacks (2 Sept. 2009)
  • $2.3 billion is 4th fine of Pfizer or a subsidiary since 2002 over illegal marketing
  • Pfizer Fact Sheet (US govt.)

Roche

| Archives |